Activity-dependent transport of GABA analogues into specific cell types demonstrated at high resolution using a novel immunocytochemical strategy

scientific article

Activity-dependent transport of GABA analogues into specific cell types demonstrated at high resolution using a novel immunocytochemical strategy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0306-4522(96)00097-8
P698PubMed publication ID8809830

P2093author name stringPow DV
Baldridge W
Crook DK
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)1129-1143
P577publication date1996-08-01
P1433published inNeuroscienceQ15708571
P1476titleActivity-dependent transport of GABA analogues into specific cell types demonstrated at high resolution using a novel immunocytochemical strategy
P478volume73

Reverse relations

cites work (P2860)
Q28508463Altered cerebral glucose and acetate metabolism in succinic semialdehyde dehydrogenase-deficient mice: evidence for glial dysfunction and reduced glutamate/glutamine cycling
Q34180560Amino acids and their transporters in the retina
Q73650407Analysis of the distribution of glycine and GABA in amacrine cells of the developing rabbit retina: a comparison with the ontogeny of a functional GABA transport system in retinal neurons
Q33982061Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children
Q42032267Contrast and glare sensitivity in epilepsy patients treated with vigabatrin or carbamazepine monotherapy compared with healthy volunteers
Q28145669Developmental expression of excitatory amino acid transporter 5: a photoreceptor and bipolar cell glutamate transporter in rat retina
Q36964911Expression of the gamma-aminobutyric acid (GABA) plasma membrane transporter-1 in monkey and human retina.
Q38101558GABA and Glutamate Uptake and Metabolism in Retinal Glial (Müller) Cells
Q44817567GABA(A) receptors in Müller glial cells of the human retina
Q34004125GABA: homeostatic and pharmacological aspects
Q44119827High-affinity GABA uptake in retinal glial (Müller) cells of the guinea pig: electrophysiological characterization, immunohistochemical localization, and modeling of efficiency
Q43772240Increased expression of GABA transporters, GAT-1 and GAT-3, in the deafferented superior colliculus of the rat.
Q34928181Neurotoxic effects of GABA-transaminase inhibitors in the treatment of epilepsy: ocular perfusion and visual performance
Q34625705Nitric oxide stimulates gamma-aminobutyric acid release and inhibits glycine release in retina
Q64096881Novel hybrid action of GABA mediates inhibitory feedback in the mammalian retina
Q36702081Ocular adverse effects associated with systemic medications : recognition and management
Q43824555Projections from the substantia nigra pars reticulata to the motor thalamus of the rat: single axon reconstructions and immunohistochemical study
Q37431696Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy
Q38086862Retinal amino acid neurochemistry in health and disease
Q50516870Symptomatic and asymptomatic visual loss in patients taking vigabatrin.
Q35106481Synaptic elements for GABAergic feed-forward signaling between HII horizontal cells and blue cone bipolar cells are enriched beneath primate S-cones.
Q41849869The Hospital for Sick Children, Toronto, Longitudinal ERG study of children on vigabatrin
Q44834128The effect of GABA and the GABA-uptake-blocker NO-711 on the b-wave of the ERG and the responses of horizontal cells to light
Q44285965The effects of GABA and vigabatrin on horizontal cell responses to light and the effect of vigabatrin on the electroretinogram
Q34882598Transport-mediated synapses in the retina
Q43686221Vigabatrin effect on inner retinal function
Q44906627Vigabatrin retinopathy in an Irish cohort: lack of correlation with dose.
Q89696134Vigabatrin-Induced Retinal Functional Alterations and Second-Order Neuron Plasticity in C57BL/6J Mice
Q37642768Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval
Q34313490Visual field defects with vigabatrin: epidemiology and therapeutic implications
Q43563239Visualising the activity of the cystine-glutamate antiporter in glial cells using antibodies to aminoadipic acid, a selectively transported substrate

Search more.